STERIS’ (TSE:STE – Free Report) – Equities research analysts at Atb Cap Markets cut their Q4 2025 earnings estimates for shares of STERIS’ in a note issued to investors on Thursday, June 27th. Atb Cap Markets analyst W. Syed now expects that the company will earn $0.03 per share for the quarter, down from their previous forecast of $0.04.
Separately, Stifel Canada lowered shares of STERIS’ from a “buy” rating to a “hold” rating in a research report on Tuesday, March 12th.
STERIS’ Price Performance
STERIS’ (TSE:STE – Get Free Report) last posted its earnings results on Wednesday, May 8th. The company reported C$0.55 earnings per share (EPS) for the quarter, topping the consensus estimate of C$0.42 by C$0.13. The firm had revenue of C$320.15 million during the quarter, compared to the consensus estimate of C$289.75 million.
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- There Are Different Types of Stock To Invest In
- Upwork Stock’s Outlook: Numbers Solid Despite Gen-AI Challenges
- Why Invest in High-Yield Dividend Stocks?
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- 3 Healthcare Dividend Stocks to Buy
- MarketBeat Week in Review – 6/24 – 6/28
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
